The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity
Romina Fiorotto(Yale University), Mario Strazzabosco(Smilow Cancer Hospital), Carlo Spirlı̀(Cancer Research Center), Peter Geibel(Yale University), R. Scirpo(Yale University), Antonis Kourtidis(Medical University of South Carolina), Massimiliano Cadamuro(University of Padua), Panos Z. Anastasiadis(Mayo Clinic in Florida), Mariangela Amenduni(Yale University), Ambra Villani(Yale University)
Cited by 73
Related Papers
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
|Hepatology|2018|340
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
|Hepatology|2020|302
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|187